#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Hepato-lenticular degeneration Mucopolysaccharidosis I Heritable pulmonary arterial hypertension Hepatic angiosarcoma Non-small cell lung cancer recurrent Arteriosclerosis Pancreatic carcinoma metastatic Oesophageal atresia B-cell small lymphocytic lymphoma refractory Autoimmune demyelinating disease Demyelination Cerebral arteriovenous malformation haemorrhagic Chronic graft versus host disease in liver Anaplastic thyroid cancer Pulmonary sarcoidosis More trials…

    Learn about Rare Diseases

    Osteosarcoma metastatic – Life with Disease Medulloblastoma – Treatment Primary immunodeficiency syndrome – Basic Information Wolfram syndrome – Life with Disease Factor IX deficiency – Basic Information Glomerulonephritis membranoproliferative Fragile X syndrome – Treatment Nephrotic syndrome Prolymphocytic leukaemia – Life with Disease Mastocytosis – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    LYSERGIDE Magnesium Sulfate Bjt-778 Other Blood Products ZUNIBERGENE ROCPARVOVEC Ketotifen Hydrogen Fumarate SULBACTAM SODIUM Tovorafenib Mannitol Artemisia Vulgaris (312) Sar-443579 Mitapivat AZD0022 ZALFERMIN Alxn2220 Gsk6097608 Hydrocortisone Hemisuccinate ALE1 Tramazoline Hydrochloride Telitacicept More therapies…

    Learn about Your Condition

    Chondropathy Ovarian epithelial cancer Monogenic diabetes Hyponatraemia Obsessive-compulsive disorder Skin papilloma Reperfusion injury Actinic keratosis Prodromal Alzheimer's disease Oral neoplasm Endolymphatic hydrops Erythema Cervix carcinoma stage I Pulmonary resection Low cardiac output syndrome More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Uncategorized

  • Safety and Tolerability Study of NBI-1065845 as Additional Treatment for Adults with Major Depressive Disorder

    Recruiting

    3 1 1
    Investigated Diseases:
    • Major depression
    Investigated Drugs:
    • 9-(4-CYCLOHEXYLOXYPHENYL)-7-METHYL-3,4-DIHYDROPYRAZINO[2,1-C][1,2,4]THIADIAZINE 2,2-DIOXIDE
    Belgium Bulgaria Croatia Czechia Estonia Finland +10

  • Study of deupsilocin besilate (CYB003) in adults with major depressive disorder comparing two doses against placebo

    Recruiting

    3 1
    Investigated Diseases:
    • Major depression
    Czechia Germany Greece Ireland Poland

  • Study of Remdesivir to Prevent Severe COVID-19 in Kidney Transplant Recipients with No or Mild Symptoms

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • COVID-19
    Investigated Drugs:
    • Remdesivir
    Spain

  • Study of TdT-3 cell therapy safety in patients aged 1 year and older with relapsed or refractory acute leukemia or lymphoblastic lymphoma

    Recruiting

    2 1 1
    Norway

  • Study of UGN-104 (mitomycin) treatment for patients with low-grade upper tract urothelial cancer

    Recruiting

    3 1 1
    Investigated Diseases:
    • Transitional cell cancer of the renal pelvis and ureter
    Investigated Drugs:
    • Mitomycin
    Bulgaria Hungary Latvia Poland Romania Spain

  • Study of lurbinectedin and irinotecan in adults and young adults with advanced desmoplastic small round cell tumor

    Recruiting

    2 1 1 1
    Investigated Drugs:
    • Lurbinectedin
    • Irinotecan Hydrochloride Trihydrate
    Italy Spain
Previous Page
1 … 144 145 146 147 148 … 1,648
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!